Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human Papillomavirus

被引:25
作者
Harper, DM
Raymond, M
Noll, WW
Belloni, DR
Duncan, LT
Cole, BF
机构
[1] Dartmouth Coll Sch Med, Dept Obstet & Gynecol, Hanover, NH USA
[2] Dartmouth Coll Sch Med, Dept Community & Family Med, Hanover, NH USA
[3] Dartmouth Coll Sch Med, Dept Pathol, Hanover, NH USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
关键词
D O I
10.1097/00007435-200211000-00003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Self-sampling for human papillomavirus (HPV) is useful for triage of ASCUS Papanicolaou (Pap) smears. Tampons with 10-second cervicovaginal cell exposure can detect HPV but appear to be less efficient than two consecutive swabs. Goal The purpose of this study was to evaluate increased vaginal tampon exposures for detecting high-risk HPV. Study Design: This longitudinal cohort study followed women who self-sampled weekly with tampons for progressively longer periods of time. A tampon was inserted for 10 seconds at the office visit and 1 hour, 4 hours, and overnight for the three subsequent home samples. Two concurrent swabs were used with each tampon sampling for contemporaneous comparisons. The MY09/MY11 PCR primer system with reverse line blot detection strips was used to detect 18 distinct high-risk HPV types. Results: Of the 309 tampons and 618 swabs used at home, 83% were returned. Among normal women, the 10-second tampon detected fewer with normal histology and high-risk HPV than did its swabs (P = 0.0412), but the 1-hour, 4-hour, and overnight tampons had high-risk-HPV detection rates equal to their swabs. In women with CIN, all tampons and swabs equally identified those with high-risk HPV. Conclusion: Self-sampling for HPV detection is acceptable, feasible, and technically accurate for both tampons with longer cervicovaginal exposures and swabs. The choice of technique is dependent on the woman, her culture, and her clinician.
引用
收藏
页码:628 / 636
页数:9
相关论文
共 32 条
[1]  
[Anonymous], DIAGNOSTIC MOL PATHO
[2]  
[Anonymous], IARC MON EV CARC RIS
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia [J].
Bowden, FJ ;
Paterson, BA ;
Mein, J ;
Savage, J ;
Fairley, CK ;
Garland, SM ;
Tabrizi, SN .
SEXUALLY TRANSMITTED INFECTIONS, 1999, 75 (06) :431-434
[5]   Human papillomavirus genotypes in rural Mozambique [J].
Castellsagué, X ;
Menéndez, C ;
Loscertales, MP ;
Kornegay, JR ;
dos Santos, F ;
Gómez-Olivé, FX ;
Lloveras, B ;
Abarca, N ;
Vaz, N ;
Barreto, A ;
Bosch, FX ;
Alonso, P .
LANCET, 2001, 358 (9291) :1429-1430
[6]   Estimates of the incidence and prevalence of sexually transmitted diseases in the United States [J].
Cates, W .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (04) :S2-S7
[7]  
Coutlee F, 1997, J MED VIROL, V51, P42, DOI 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO
[8]  
2-S
[9]   TAMPONS - A NOVEL PATIENT-ADMINISTERED METHOD FOR THE ASSESSMENT OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION [J].
FAIRLEY, CK ;
CHEN, SJ ;
TABRIZI, SN ;
QUINN, MA ;
MCNEIL, JJ ;
GARLAND, SM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1103-1106
[10]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357